Igea Pharma N.v. buy melinda
Start price
14.04.21
/
50%
€0.33
Target price
14.04.22
€0.45
Performance (%)
-96.82%
End price
15.04.22
€0.011
Summary
This prediction ended on 15.04.22 with a price of €0.011. Massive losses of -96.82% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Igea Pharma N.v. | - | - | - | - |
iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
According to melinda what are the pros and cons of Igea Pharma N.v. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Igea Pharma N.v. diskutieren
Buy mit Kursziel 0,45
In the thread Trading Igea Pharma N.v.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Igea Pharma N.v.
Igea Pharma N.v.
Start price
Target price
Perf. (%)
€0.39
28.03.21
28.03.21
€0.55
28.03.22
28.03.22
-15.38%
14.04.21
14.04.21
Could be worthwhile Investment >10% per year
Igea Pharma N.v.
Start price
Target price
Perf. (%)
€0.48
09.08.20
09.08.20
€0.70
27.08.20
27.08.20
21.34%
27.08.20
27.08.20
Could be worthwhile Investment >10% per year